|
|
Substance Name: Convallatoxin
RN: 508-75-8
UNII: JY264VIR1Y
InChIKey: HULMNSIAKWANQO-JQKSAQOKSA-N
Note
- PI: *CONVALLARIA (73-79).
Molecular Formula
- C29-H42-O10
Molecular Weight
- 550.6408
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Cardiovascular Agents
- Drug / Therapeutic Agent
- Natural Product
- Vasodilator Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Convallatoxin
Synonyms
- 3beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide
- Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-
- Convallaotoxin
- Convallaton
- Convallatoxin
- Convallatoxoside
- Convallotoxin
- Corglycon
- Corglycone
- Corglykon
- EINECS 208-086-3
- HSDB 3475
- Korglykon
- Mannopyranoside, strophanthidin-3,6-deoxy-, alpha-L-
- NSC 407808
- Rhamnoside, strophanthidin-3, alpha-L-
- Strophanthidin alpha-L-rhamnoside
- Strophanthidin, 3-(6-deoxy-alpha-L-mannopyranoside)
- UNII-JY264VIR1Y
Systematic Names
- Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)- (9CI)
- Convallatoxin
Registry Numbers
CAS Registry Number
- 508-75-8
FDA UNII
- JY264VIR1Y
System Generated Number
- 0000508758
Structure Descriptors
InChI
1S/C29H42O10/c1-15-22(32)23(33)24(34)25(38-15)39-17-3-8-27(14-30)19-4-7-26(2)18(16-11-21(31)37-13-16)6-10-29(26,36)20(19)5-9-28(27,35)12-17/h11,14-15,17-20,22-25,32-36H,3-10,12-13H2,1-2H3/t15-,17-,18+,19-,20+,22-,23+,24+,25-,26+,27-,28-,29-/m0/s1InChIKey
HULMNSIAKWANQO-JQKSAQOKSA-NSmiles
C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD50 | intraduodenal | 2100ug/kg (2.1mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
cat | LD50 | intraperitoneal | 180ug/kg (0.18mg/kg) | Acta Biologica et Medica Germanica. Vol. 12, Pg. 434, 1964. | |
cat | LD50 | intravenous | 74ug/kg (0.074mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 74, Pg. 223, 1942. | |
cat | LD50 | oral | 3650ug/kg (3.65mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
cat | LDLo | unreported | 50ug/kg (0.05mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 148, Pg. 471, 1964. | |
frog | LD50 | subcutaneous | 440ug/kg (0.44mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
frog | LDLo | intravenous | 300ug/kg (0.3mg/kg) | Merck Index. Vol. 10, Pg. 357, 1983. | |
guinea pig | LD50 | intraperitoneal | 200ug/kg (0.2mg/kg) | Acta Biologica et Medica Germanica. Vol. 12, Pg. 434, 1964. | |
guinea pig | LD50 | intravenous | 185ug/kg (0.185mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
guinea pig | LD50 | oral | > 50mg/kg (50mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
guinea pig | LD95 | intraduodenal | 10490ug/kg (10.49mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
monkey | LDLo | intravenous | 90ug/kg (0.09mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 412, 1963. | |
mouse | LD50 | intraperitoneal | 10mg/kg (10mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 155, Pg. 165, 1965. | |
mouse | LD50 | intravenous | 1mg/kg (1mg/kg) | U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#00462, | |
mouse | LD50 | oral | > 2gm/kg (2000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 557, 1958. | |
mouse | LD50 | subcutaneous | 15mg/kg (15mg/kg) | Farmakologiya i Toksikologiya Vol. 44, Pg. 342, 1981. | |
pig | LDLo | intraduodenal | 3170ug/kg (3.17mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 229, 1970. | |
pig | LDLo | intravenous | 50ug/kg (0.05mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 229, 1970. | |
pigeon | LDLo | intravenous | 248ug/kg (0.248mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 412, 1963. | |
rat | LD50 | intravenous | 15200ug/kg (15.2mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 848, 1961. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 238 | deg C | EXP | |
log P (octanol-water) | -0.48 | (none) | EXP | |
Water Solubility | 500 | mg/L | 25 | EXP |
Vapor Pressure | 1.82E-22 | mm Hg | 25 | EST |
Henry's Law Constant | 2.51E-21 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 1.72E-10 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.